ArticleBiology methods & protocols2026

Comparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatide.

Karthik Murugadoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.